<?xml version="1.0" encoding="UTF-8"?>
<p id="para170">Preliminary trials against Ebola yielded promising results, and in 2018 Gilead tested the drug in a large-scale clinical trial during an Ebola outbreak in the Democratic Republic of the Congo. When this showed that remdesivir 
 <ext-link ext-link-type="uri" xlink:href="https://www.nejm.org/doi/full/10.1056/NEJMoa1910993" id="interrefs120" xmlns:xlink="http://www.w3.org/1999/xlink">didn't prevent deaths as well as other treatments</ext-link>, it was shelved.
</p>
